Solana Co. Files 8-K with Financials

TL;DR

Solana Co. (fka Helius Medical) filed an 8-K on 10/20/25 with financials & Reg FD updates.

AI Summary

On October 20, 2025, Solana Co. (formerly Helius Medical Technologies, Inc.) filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. The company is incorporated in Delaware and its principal executive offices are located at 642 Newtown Yardley Road, Suite 100, Newtown, PA 18940.

Why It Matters

This 8-K filing provides updated information and disclosures for Solana Co., which is important for investors to stay informed about the company's financial status and regulatory compliance.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting financial statements and disclosures, not indicating any immediate operational or financial distress.

Key Players & Entities

• Solana Co. (company) — Registrant
• Helius Medical Technologies, Inc. (company) — Former company name
• October 20, 2025 (date) — Date of earliest event reported
• October 21, 2025 (date) — Filing date
• 642 Newtown Yardley Road, Suite 100, Newtown, PA 18940 (address) — Principal executive office address

FAQ

Key Financial Figures

• $0.001 — hich registered Class A Common Stock, $0.001 par value HSDT The Nasdaq Stock Mar

Filing Documents

• hsdt-20251020x8k.htm (8-K) — 42KB
• hsdt-20251020xex99d1.htm (EX-99.1) — 22KB
• hsdt-20251020x8k001.jpg (GRAPHIC) — 6KB
• 0001104659-25-100920.txt ( ) — 197KB
• hsdt-20251020.xsd (EX-101.SCH) — 3KB
• hsdt-20251020_lab.xml (EX-101.LAB) — 16KB
• hsdt-20251020_pre.xml (EX-101.PRE) — 10KB
• hsdt-20251020x8k_htm.xml (XML) — 5KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On October 20, 2025, Solana Company (formerly known as Helius Medical Technologies, Inc.) (the "Company") issued a press release. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. Information contained on or accessible through any website reference in the press release is not part of, or incorporated by reference in, this report, and the inclusion of such website addresses in this report by incorporation by reference of the press release is as inactive textual references only. Exhibit 99.1 hereto contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are based on current expectations and are not guarantees of future performance. Further, the forward-looking statements are subject to the limitations listed in Exhibit 99.1 and in the other reports of the Company filed with the Securities and Exchange Commission, including that actual events or results may differ materially from those in the forward-looking statements. The information in this report, including Exhibit 99.1 hereto, is furnished pursuant to Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. The Company's submission of this report shall not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated October 20, 2025 . 104 Cover Page Interactive Data File (embedded within Inline XBRL document). 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SOLANA COMPANY. Dated: October 20, 2025 By: /s/ Joseph Chee Joseph Chee Executive Chairman 3

View Full Filing

View this 8-K filing on SEC EDGAR